Selective serotonin reuptake inhibitor

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Selective serotonin reuptake inhibitors or SSRIs are a class of antidepressants]. They increase serotonin levels by blocking the brain's reabsorption of that neurotransmitter.[1] Some SSRIs are also used to treat some other conditions, including some anxiety disorders.[1]

Theory

Evidence

As of May 2018, the FDA has approved the following SSRIs to treat depression:[1]

Fluvoxamine (Luvox) is an SSRI approved to treat obsessive-compulsive disorder and is sometimes also used to treat depression.[1]

Clinicians

Risks and safety

Costs and availability

See also

References

  1. 1.0 1.1 1.2 1.3 "Selective serotonin reuptake inhibitors (SSRIs)". Mayo Clinic. Retrieved January 8, 2019.